Cadrenal Therapeutics, Inc. Common Stock

CVKD · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$3-$4-$4-$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$1
Change in WC-$0$0-$1$2
Other Non-Cash$0$0$0-$0
Operating Cash Flow-$2-$3-$5-$2
Investing Activities
PP&E Inv.-$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1$1$2$4
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0$0$4
Financing Cash Flow$1$1$2$7
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$2-$3$6
Supplemental Information
Beg. Cash$6$7$10$4
End Cash$4$6$7$10
Free Cash Flow-$2-$3-$5-$2
Cadrenal Therapeutics, Inc. Common Stock (CVKD) Financial Statements & Key Stats | AlphaPilot